Drugs · acquisition-cost intelligence
Plexion
Sodium Sulfacetamide 9.8% and Sulfur 4.8%· ingredient sulfacetamideAntiinfectives for treatment of acne· SULFACETAMIDE SODIUM 98 mg/g; SULFUR 48 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.12999
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other sulfacetamide products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| Sodium Sulfacetamide 8% and Sulfur 4% | $0.06467 | −$0.06530 |
| Sodium Sulfacetamide 9% and Sulfur 4.5% Cleanser | $0.07818 | −$0.05180 |
| OVACE | $0.11417 | −$0.01580 |
| AVAR | $0.17118 | +$0.04120 |
| Sodium Sulfacetamide 9% and Sulfur 4% Cleanser | $0.36031 | +$0.23030 |
| Klaron | $0.53594 | +$0.40590 |
| Avar-e | $0.68695 | +$0.55700 |
| sulfacetamide sodium | $1.86 | +$1.73 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.